NO874241D0 - Terapeutisk aktive salter. - Google Patents
Terapeutisk aktive salter.Info
- Publication number
- NO874241D0 NO874241D0 NO874241A NO874241A NO874241D0 NO 874241 D0 NO874241 D0 NO 874241D0 NO 874241 A NO874241 A NO 874241A NO 874241 A NO874241 A NO 874241A NO 874241 D0 NO874241 D0 NO 874241D0
- Authority
- NO
- Norway
- Prior art keywords
- pct
- therapeutic active
- active salts
- sec
- date
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8619382A IT1213034B (it) | 1986-02-12 | 1986-02-12 | Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale. |
| PCT/EP1987/000068 WO1987005024A1 (en) | 1986-02-12 | 1987-02-12 | Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO874241D0 true NO874241D0 (no) | 1987-10-09 |
| NO874241L NO874241L (no) | 1987-12-09 |
Family
ID=11157215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO874241A NO874241L (no) | 1986-02-12 | 1987-10-09 | Terapeutisk aktive salter. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4950776A (no) |
| EP (1) | EP0256069B1 (no) |
| JP (1) | JPH0780775B2 (no) |
| KR (1) | KR940011187B1 (no) |
| AT (1) | ATE71385T1 (no) |
| AU (1) | AU601403B2 (no) |
| CA (1) | CA1291766C (no) |
| DE (1) | DE3775854D1 (no) |
| DK (1) | DK169339B1 (no) |
| FI (1) | FI874450A7 (no) |
| HU (1) | HU199148B (no) |
| IE (1) | IE59283B1 (no) |
| IL (1) | IL81549A0 (no) |
| IT (1) | IT1213034B (no) |
| NO (1) | NO874241L (no) |
| NZ (1) | NZ219259A (no) |
| PH (1) | PH24445A (no) |
| WO (1) | WO1987005024A1 (no) |
| ZA (1) | ZA871032B (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0348859A1 (en) * | 1988-07-01 | 1990-01-03 | MAGIS FARMACEUTICI S.p.A. | 1,2-di-O-acyl glycero(DI)phosphate of L-carnitine and its derivatives, a process for their preparation and pharmaceutical formulations which contain them |
| IT1230140B (it) * | 1989-05-03 | 1991-10-14 | Fidia Spa | Derivati della serina, loro processo di preparazione e impiego in terapia umana |
| IT1231776B (it) * | 1989-08-07 | 1991-12-21 | Magis Farmaceutici | Processo per preparare i derivati acetilati della l alfa glicerofosforil serina. |
| IT1254471B (it) * | 1992-02-27 | 1995-09-25 | Magis Farmaceutici | Derivati ammidici della (r)-glicerofosforil-(s)-serina o del suo diacil derivato, un processo per la loro preparazione e relative composizioni farmaceutiche per il potenziamento dei processi di apprendimento |
| IT1265647B1 (it) * | 1992-11-18 | 1996-11-22 | Farmin Srl | Composizione farmaceutiche topiche per le allergie respiratorie |
| JP6195949B2 (ja) | 2016-02-26 | 2017-09-13 | 株式会社リケン | ピストンリング |
| CN108558937B (zh) * | 2018-04-19 | 2019-05-24 | 厦门大学 | 一种L-α-甘油磷脂酰丝氨酸及其合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55115824A (en) * | 1979-02-28 | 1980-09-06 | Nippon Shoji Kk | Remedy for clouding of consciousness and sensomobile disorder |
| IT1123142B (it) * | 1979-09-14 | 1986-04-30 | Lpb Ist Farm | Uso di glicerilfosforil derivati nella terapia di dislipemie ed epatiti,e composizioni farmaceutiche relative |
| DE3212387A1 (de) * | 1982-04-02 | 1983-10-13 | Bayer Ag, 5090 Leverkusen | Glycerinphosphatide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| US4624852A (en) * | 1983-05-16 | 1986-11-25 | Massachusetts Institute Of Technology | Process and composition for treating neurological disorders and aging |
| JPS6081193A (ja) * | 1983-10-11 | 1985-05-09 | Takeda Chem Ind Ltd | リン脂質 |
| IT1212900B (it) * | 1983-11-17 | 1989-11-30 | Valle Francesco Della | Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna |
| IT1199972B (it) * | 1985-05-08 | 1989-01-05 | Lpb Ist Farm | Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale |
-
1986
- 1986-02-12 IT IT8619382A patent/IT1213034B/it active
-
1987
- 1987-02-12 AU AU70250/87A patent/AU601403B2/en not_active Ceased
- 1987-02-12 AT AT87901055T patent/ATE71385T1/de not_active IP Right Cessation
- 1987-02-12 CA CA000529554A patent/CA1291766C/en not_active Expired - Lifetime
- 1987-02-12 JP JP62501166A patent/JPH0780775B2/ja not_active Expired - Lifetime
- 1987-02-12 KR KR1019870700914A patent/KR940011187B1/ko not_active Expired - Fee Related
- 1987-02-12 HU HU871033A patent/HU199148B/hu not_active IP Right Cessation
- 1987-02-12 FI FI874450A patent/FI874450A7/fi not_active IP Right Cessation
- 1987-02-12 IE IE36187A patent/IE59283B1/en not_active IP Right Cessation
- 1987-02-12 PH PH34851A patent/PH24445A/en unknown
- 1987-02-12 NZ NZ219259A patent/NZ219259A/xx unknown
- 1987-02-12 ZA ZA871032A patent/ZA871032B/xx unknown
- 1987-02-12 US US07/112,000 patent/US4950776A/en not_active Expired - Fee Related
- 1987-02-12 WO PCT/EP1987/000068 patent/WO1987005024A1/en not_active Ceased
- 1987-02-12 IL IL81549A patent/IL81549A0/xx not_active IP Right Cessation
- 1987-02-12 EP EP87901055A patent/EP0256069B1/en not_active Expired - Lifetime
- 1987-02-12 DE DE8787901055T patent/DE3775854D1/de not_active Expired - Fee Related
- 1987-10-09 NO NO874241A patent/NO874241L/no unknown
- 1987-10-12 DK DK532087A patent/DK169339B1/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE71385T1 (de) | 1992-01-15 |
| ZA871032B (en) | 1987-08-04 |
| NO874241L (no) | 1987-12-09 |
| HUT47299A (en) | 1989-02-28 |
| NZ219259A (en) | 1989-04-26 |
| FI874450L (fi) | 1987-10-09 |
| IT8619382A0 (it) | 1986-02-12 |
| IT1213034B (it) | 1989-12-07 |
| KR940011187B1 (ko) | 1994-11-26 |
| AU7025087A (en) | 1987-09-09 |
| DK532087A (da) | 1987-10-12 |
| HU199148B (en) | 1990-01-29 |
| IE59283B1 (en) | 1994-02-09 |
| FI874450A0 (fi) | 1987-10-09 |
| KR880700805A (ko) | 1988-04-12 |
| AU601403B2 (en) | 1990-09-13 |
| JPH0780775B2 (ja) | 1995-08-30 |
| DE3775854D1 (de) | 1992-02-20 |
| CA1291766C (en) | 1991-11-05 |
| EP0256069A1 (en) | 1988-02-24 |
| FI874450A7 (fi) | 1987-10-09 |
| JPS63502893A (ja) | 1988-10-27 |
| WO1987005024A1 (en) | 1987-08-27 |
| IL81549A0 (en) | 1987-09-16 |
| DK169339B1 (da) | 1994-10-10 |
| PH24445A (en) | 1990-06-25 |
| US4950776A (en) | 1990-08-21 |
| DK532087D0 (da) | 1987-10-12 |
| EP0256069B1 (en) | 1992-01-08 |
| IE870361L (en) | 1987-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE19375061I2 (de) | Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung. | |
| AU562938B2 (en) | 7, 10, 13, 16 docosatetraenoic acid composition | |
| FI884924L (fi) | Humanimmuglobulin som producerats med hybrid-dna-teknik. | |
| DE3882899D1 (de) | Mehrschicht-kollimator und diesen verwendende vorrichtung. | |
| GR3019179T3 (en) | Flupirtine in combination with antiparkinsonica against muscle bracing | |
| FI875326A7 (fi) | Valonsäteilyttäjälaite korvan lääketieteelliseen hoitoon. | |
| FI891245L (fi) | Starka soetningsmedel. | |
| NO874241D0 (no) | Terapeutisk aktive salter. | |
| ATE87476T1 (de) | Fluessige orale formulierung. | |
| DE3867086D1 (de) | Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen. | |
| IL90499A0 (en) | Therapeutic uses of 2',5'-oligoadenylates | |
| DE3462688D1 (en) | 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases | |
| DK284588A (da) | Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler. | |
| AU1621888A (en) | Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes | |
| GR3005231T3 (no) | ||
| DE69009765D1 (de) | Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| IT8720800A0 (it) | Composto attivo nella terapia carciovascolare. | |
| IT8423800A0 (it) | Procedimento di trattamento di stati ipotrofici nel bambino mediante somministrazioni di aspartato di arginina. | |
| NO880639D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oksimetere av 2,6-dioksabicyklo (3, 3, 0)oktanoner. | |
| MX9203508A (es) | 1,7-difenil-3-metilaza -7-ciano-8-metilnonano para usarse en el tratamiento de enfermedades. | |
| IT8602913A0 (it) | Metodo per l'isolamento protettivo di vitamine, e altre sostanze di facile alterazione chimica. | |
| SG13194G (en) | Pharmaceutical composition for treating inflammation in the eye. | |
| ATE70840T1 (de) | Benzothiepino(5,4-c>pyridazin-verbindungen und ihre pharmazeutischen wirkungen. |